Showing results (1841-1850 of 2,034) with videos related to
Sort By:
Pageof 204
Biological Psychiatry|June 8, 2019
Impact of Polygenic Risk for Schizophrenia on Cortical Structure in UK BiobankEmma Neilson, Xueyi Shen, Simon R Cox, et al.Gut|January 25, 2018
Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trialWee Sing Ngu, Roisin Bevan, Zacharias P Tsiamoulos, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapyLouisa Alim, Siddharth Adityan, Rui Chen, et al.American Heart Journal|November 7, 2015
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failureShelby D Reed, Matthew P Neilson, Matthew Gardner, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|March 19, 2021
Childhood obesity prevention across borders: A National Institutes of Health commentarySusan Vorkoper, S Sonia Arteaga, David Berrigan, et al.Journal of Clinical Epidemiology|March 13, 2012
Introducing GRADE across the NICE clinical guideline programJudith Thornton, Philip Alderson, Toni Tan, et al.Oncogene|May 28, 2013
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expressionT Sato, T H Tran, A R Peck, et al.The Plant Genome|March 6, 2018
Verticillium dahliae Disease Resistance and the Regulatory Pathway for Maturity and Tuberization in PotatoHelen H Tai, David De Koeyer, Mads Sønderkær, et al.Lancet (London, England)|June 15, 2024
Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trialChristopher Burton, Cara Mooney, Laura Sutton, et al.Nature Cancer|February 5, 2022
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasisHin Ching Lo, Zhan Xu, Ik Sun Kim, et al.Pageof 204